These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 8550766)

  • 1. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
    Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
    Chang YT; Kappy MS; Iwamoto K; Wang J; Yang X; Pang S
    Pediatr Res; 1993 Nov; 34(5):698-700. PubMed ID: 8284113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.
    Pang S; Wang W; Rich B; David R; Chang YT; Carbunaru G; Myers SE; Howie AF; Smillie KJ; Mason JI
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2556-63. PubMed ID: 12050213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
    Rhéaume E; Sanchez R; Simard J; Chang YT; Wang J; Pang S; Labrie F
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1012-8. PubMed ID: 7962268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
    Simard J; Rhéaume E; Sanchez R; Laflamme N; de Launoit Y; Luu-The V; van Seters AP; Gordon RD; Bettendorf M; Heinrich U
    Mol Endocrinol; 1993 May; 7(5):716-28. PubMed ID: 8316254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Lutfallah C; Wang W; Mason JI; Chang YT; Haider A; Rich B; Castro-Magana M; Copeland KC; David R; Pang S
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
    Sakkal-Alkaddour H; Zhang L; Yang X; Chang YT; Kappy M; Slover RS; Jorgensen V; Pang S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3961-5. PubMed ID: 8923844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT; Zhang L; Alkaddour HS; Mason JI; Lin K; Yang X; Garibaldi LR; Bourdony CJ; Dolan LM; Donaldson DL
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency.
    Sanchez R; Rhéaume E; Laflamme N; Rosenfield RL; Labrie F; Simard J
    J Clin Endocrinol Metab; 1994 Mar; 78(3):561-7. PubMed ID: 8126127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
    Simard J; Moisan AM; Morel Y
    Semin Reprod Med; 2002 Aug; 20(3):255-76. PubMed ID: 12428206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene.
    Mébarki F; Sanchez R; Rhéaume E; Laflamme N; Simard J; Forest MG; Bey-Omar F; David M; Labrie F; Morel Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2127-34. PubMed ID: 7608265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty.
    Alos N; Moisan AM; Ward L; Desrochers M; Legault L; Leboeuf G; Van Vliet G; Simard J
    J Clin Endocrinol Metab; 2000 May; 85(5):1968-74. PubMed ID: 10843183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin.
    Simard J; Rhéaume E; Leblanc JF; Wallis SC; Joplin GF; Gilbey S; Allanson J; Mettler G; Bettendorf M; Heinrich U
    Hum Mol Genet; 1994 Feb; 3(2):327-30. PubMed ID: 8004103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Johannsen TH; Mallet D; Dige-Petersen H; Müller J; Main KM; Morel Y; Forest MG
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2076-80. PubMed ID: 15671104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss.
    Russell AJ; Wallace AM; Forest MG; Donaldson MD; Edwards CR; Sutcliffe RG
    J Mol Endocrinol; 1994 Apr; 12(2):225-37. PubMed ID: 8060486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel homozygous nonsense mutations E135* in the type II 3beta-hydroxysteroid dehydrogenase gene in a girl with salt-losing congenital adrenal hyperplasia. Mutations in brief no. 168. Online.
    Marui S; Torrealba IM; Russell AJ; Latronico AC; Sutcliffe RG; Mendonca BB
    Hum Mutat; 1998; 12(2):139. PubMed ID: 10694926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
    Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI
    J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.
    Rhéaume E; Simard J; Morel Y; Mebarki F; Zachmann M; Forest MG; New MI; Labrie F
    Nat Genet; 1992 Jul; 1(4):239-45. PubMed ID: 1363812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships of 3 beta-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3 beta-hydroxysteroid dehydrogenase deficiency.
    Morel Y; Mébarki F; Rhéaume E; Sanchez R; Forest MG; Simard J
    Steroids; 1997 Jan; 62(1):176-84. PubMed ID: 9029734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyl-terminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia.
    Welzel M; Wüstemann N; Simic-Schleicher G; Dörr HG; Schulze E; Shaikh G; Clayton P; Grötzinger J; Holterhus PM; Riepe FG
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1418-25. PubMed ID: 18252794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.